Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study

Published:2020-06-11 Issue:3 Volume:44 Page:1447-1455
ISSN:0344-5607
Container-title:Neurosurgical Review
language:en
Short-container-title:Neurosurg Rev

Author:

Wang Jingjing,Yan Lvjun,Ai Ping,He Yan,Guan Hui,Wei Zhigong,He Ling,Mu Xiaoli,Liu Yanhui,Peng Xingchen^ORCID

Funder

National Natural Science Foundation of China

Sichuan Province Science and Technology Support Program

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10143-020-01326-y.pdf

Reference24 articles.

1. Kleihues P, Burger PC, Scheithauer BW, Zülch KJ (1993) Histological typing of tumours of the central nervous system, vol no.21International histological classification of tumours, 2nd edn. Springer-Verlag,

2. Tandon A, Schiff D (2014) Therapeutic decision making in patients with newly diagnosed low grade glioma. Current Treatment Options in Oncology 15(4):529–538. https://doi.org/10.1007/s11864-014-0304-6

3. Komori T (2017) The 2016 WHO classification of tumours of the central nervous system: the major points of revision. Neurologia medico-chirurgica 57(7):301–311. https://doi.org/10.2176/nmc.ra.2017-0010

4. Soffietti R, Baumert BG, Bello L, von Deimling A, Duffau H, Frenay M et al (2010) Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force. Eur J Neurol 17(9):1124–1133. https://doi.org/10.1111/j.1468-1331.2010.03151.x

5. van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K et al (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet (London, England) 366(9490):985–990. https://doi.org/10.1016/s0140-6736(05)67070-5

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GBM immunotherapy: Exploring molecular and clinical frontiers;Life Sciences;2024-11

2. A systematic review and meta-analysis informing the role of adjuvant radiotherapy (RT) in Grade 2 and 3 oligodendroglioma;Journal of Clinical Neuroscience;2024-08

3. The role of apparent diffusion coefficient in the grading of adult isocitrate dehydrogenase-mutant astrocytomas: relationship with the Ki-67 proliferation index;Acta Radiologica;2024-04-22

4. Epigenetic dysregulation in cancers by isocitrate dehydrogenase 2 (IDH2);Advances in Protein Chemistry and Structural Biology;2024

5. Effectiveness and Safety of Different Postoperative Adjuvant Regimens in Patients with Low-Grade Gliomas: A Network Meta-Analysis;World Neurosurgery;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3